Lilly buys AtaiBeckley·$3.8bnOtsuka buys Transcend·$1.2bnAbbVie buys Gilgamesh·$1.2bnatai buys Beckley Psytech·terms undisclosedAbbVie takes an option on Gilgamesh·$2bnLilly buys AtaiBeckley·$3.8bnOtsuka buys Transcend·$1.2bnAbbVie buys Gilgamesh·$1.2bnatai buys Beckley Psytech·terms undisclosedAbbVie takes an option on Gilgamesh·$2bnLilly buys AtaiBeckley·$3.8bnOtsuka buys Transcend·$1.2bnAbbVie buys Gilgamesh·$1.2bnatai buys Beckley Psytech·terms undisclosedAbbVie takes an option on Gilgamesh·$2bn
Next issueIssue 16 · Tue 29 Sep 

Companies

Region Skane

HQ
Sweden
Status
active
Listing
Private
Current stage
academic/public sponsor

clinicaltrials.govregistryverified 2026-08-24

Notes on the record

Public healthcare region, not a company. Included because it is the sponsor of record for A008. Diacritic dropped from Skane for CSV safety.

Assets

Registered trials

Deals

This company is not a party to any row in data/deals.csv.

In the briefing

1 issue tagged REGION-SKANE.